Mueser, KT, McGurk, SR. Schizophrenia.
2004; 363: 2063–72.
Isaac, M, Chand, P, Murthy, P. Schizophrenia outcome measures in the wider
international community. Br J Psychiatry
2007; 191 (suppl 50):
World Health Organization. Schizophrenia: An
International Follow-up Study. John Wiley and
Jablensky, A, Sartorius, N, Ernberg, G, Anker, M, Korten, A, Cooper, JE, et al. Schizophrenia: manifestation, incidence and
course in different cultures. A World Health Organization ten-country
study. Psychol Med Monogr Suppl
Harrison, G., Hopper, K, Craig, T, Laska, E, Siegel, C, Wanderling, J, et al. Recovery from psychotic illness: a 15- and
25-year international follow-up study. Br J
2001; 178: 506–17.
Hopper, K, Harrison, G, Janca, A, Sartorius, N. Recovery from Schizophrenia: An International
Perspective. Oxford University
Ran, MS, Chen, EYH, Conwell, Y, Chan, CLW, Yip, PSF, Xiang, MZ, et al. Mortality in people with schizophrenia in
rural China. 10-year cohort study
Br J Psychiatry
2007; 190: 237–42.
Cohen, A, Patel, V, Thara, R, Gureje, O. Questioning an axiom: Better prognosis for
schizophrenia in the developing world?
2008; 34: 229–44.
Padmavathi, R, Rajkumar, S, Srinivasan, TN. Schizophrenic patients who were never treated – a
study in an Indian urban community. Psychol
1998; 28: 1113–7.
Ran, MS, Xiang, MZ, Huang, MS, Shan, YH. Natural course of schizophrenia: 2-year follow-up
study in a rural Chinese community. Br J
2001; 178: 154–8.
Kurihara, T, Kato, M, Reverger, R, Tirta, IGR, Kashima, H. Never-treated patients with schizophrenia in the
developing country of Bali. Schizophr
2005; 79: 307–13.
Harris, EC, Barraclough, B. Suicide as an outcome for mental disorders. A
meta-analysis. Br J Psychiatry
1997; 170: 205–28.
Saha, S, Chant, D, McGrath, J. A systematic review of mortality in schizophrenia –
is the differential mortality gap worsening over time?
Arch Gen Psychiatry
2007; 64: 1123–32.
Mortensen, PB, Juel, K. Mortality and causes of death in first admitted
schizophrenic patients. Br J Psychiatry
1993; 163: 183–9.
De Hert, M, Peuskens, J. Psychiatric aspects of suicidal behavior:
schizophrenia. In International Handbook of
Suicide and Attempted Suicide (eds Hawton, K, van Heeringen, K): 121–34. John Wiley and Sons,
Phillips, MR, Yang, GH, Li, SR, Li, Y. Suicide and the unique prevalence pattern of
schizophrenia in mainland China: a retrospective observational
2004; 364: 1062–8.
Ran, MS, Chen, EYH. Suicide and schizophrenia in China.
2004; 364: 1016–7.
Xiang, M, Ran, M, Li, S. A controlled evaluation of psychoeducation family
intervention in a rural Chinese community. Br J
1994; 165: 544–8.
Tirupati, SN, Padmavati, R, Thara, R, McCreadie, RG. Psychopathology in never-treated
schizophrenia. Compr Psychiatry
Ran, MS, Xiang, MZ, Li, SX, Shan, YH, Huang, MS, Li, SG, et al. Prevalence and outcome of schizophrenia in a
Chinese rural area: an epidemiological study.
Aust N Z J Psychiatry
2003; 37: 452–7.
World Health Organization. The ICD–10
Classification of Mental and Behavioral Disorders: Clinical Descriptions
and Diagnostic Guidelines. WHO,
Wing, JK, Cooper, JE, Sartorius, N. The Measurement and Classification of Psychiatric
Symptoms. Cambridge University
Liu, JQ, Wang, CH. Social Disability Screening Schedule
(SDSS). In Handbook of Mental Illness
Epidemiological Investigation (eds Shen, YC, Wang, CH): 60–7. People Health Press,
Storosum, JG, van Zwieten, BJ, Wohlfarth, T, de Haan, L, Khan, A, van den Brink, W. Suicide risk in placebo vs active treatment in
placebo-controlled trials for schizophrenia. Arch
2003; 60: 365–8.
Rathbone, J, Zhang, L, Zhang, MM, Xia, J, Liu, X, Yang, Y, et al. Chinese herbal medicine for schizophrenia.
Cochrane systematic review of randomised trials.
Br J Psychiatry
2007; 190: 379–84.
Montout, C, Casadebaig, F, Lagnaoui, R, Verdoux, H, Philippe, A, Begaud, B, et al. Neuroleptics and mortality in schizophrenia:
prospective analysis of deaths in a French cohort of schizophrenic
patients. Schizophr Res
2002; 57: 147–56.
Qin, P, Nordentoft, M. Suicide risk in relation to psychiatric
hospitalization: evidence based on longitudinal
registers. Arch Gen Psychiatry
2005; 62: 427–32.
Palmer, BA, Pankratz, VS, Bostwick, JM. The lifetime risk of suicide in schizophrenia: a
reexamination. Arch Gen Psychiatry
2005; 62: 247–53.
Jeste, DV, Harris, MJ, Krull, AJ, Kuck, J, McAdams, LA, Heaton, R. Clinical and neuropsychological characteristics of
patients with late-onset schizophrenia. Am J
1995; 152: 722–30.
Black, K, Peters, L, Rui, Q, Milliken, H, Whitehorn, D, Kopala, LC. Duration of untreated psychosis predicts treatment
outcome in an early psychosis program. Schizophr
2001; 47: 215–22.
Ran, MS, Xiang, MZ, Conwell, Y, Lamberti, JS, Huang, MS, Shan, YH, et al. Comparison of characteristics between
geriatric and younger subjects with schizophrenia in
community. J Psychiatric Res
2004; 38: 417–24.
Gureje, O, Bamidele, R. Thirteen-year social outcome among Nigerian
outpatients with schizophrenia. Soc Psychiatry
1999; 34: 147–51.
Green, AI, Canuso, CM, Brenner, MJ, Wojcik, JD. Detection and management of comorbidity in patients
with schizophrenia. Psychiatr Clin North
2003; 26: 115–39.
Goff, DC, Cather, C, Evins, AE, Henderson, DC, Freudenreich, O, Copeland, PM, et al. Medical morbidity and mortality in
schizophrenia: guidelines for psychiatrists. J
2005; 66: 183–94.
World Health Organization. Project Atlas: Mapping
Mental Health Resources Around the World.
Oosthuizen, P, Emsley, RA, Keyter, N, Niehaus, DJ, Koen, L. Duration of untreated psychosis and outcome in
first-episode psychosis. Perspective from a developing
country. Acta Psychiatr Scand
2005; 111: 214–9.
Tirupati, NS, Rangaswamy, T, Raman, P. Duration of untreated psychosis and treatment
outcome in schizophrenia patients untreated for many
years. Aust N Z J Psychiatry
2004; 38: 339–43.
Ran, MS, Chan, CLW, Chen, EYH, Xiang, MZ, Caine, ED, Conwell, Y. Homelessness among patients with schizophrenia in
rural China: a 10-year cohort study. Acta
2006; 114: 118–23.